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ABSTRACT
Objective The cross- sectional association between 
accelerometer- measured physical activity (PA), sedentary 
behaviour (SB) and cardiac structure and function is less 
well described. This study’s primary aim was to compare 
echocardiographic measures of cardiac structure and 
function with accelerometer measured PA and SB.
Methods Participants included 1206 self- identified 
Hispanic/Latino men and women, age 45–74 years, 
from the Echocardiographic Study of Latinos. Standard 
echocardiographic measures included M- mode, two- 
dimensional, spectral, tissue Doppler and myocardial 
strain. Participants wore an Actical accelerometer at the 
hip for 1 week.
Results The mean±SE age for the cohort was 56±0.4 
years, 57% were women. Average moderate to vigorous 
PA (MVPA) was 21±1.1 min/day, light PA was 217±4.2 min/
day and SB was 737±8.1 min/day. Both higher levels 
of light PA and MVPA (min/day) were associated with 
lower left ventricular (LV) mass index (LVMI)/end- diastolic 
volume and a lower E/e′ ratio. Higher levels of MVPA 
(min/day) were associated with better right ventricular 
systolic function. Higher levels of SB were associated with 
increased LVMI. In a multivariable linear regression model 
adjusted for demographics and cardiovascular disease 
modifiable factors, every 10 additional min/day of light PA 
was associated with a 0.03 mL/m2 increase in left atrial 
volume index (LAVI) (p<0.01) and a 0.004 cm increase 
in tricuspid annular plane systolic excursion (p<0.01); 
every 10 additional min/day of MVPA was associated with 
a 0.18 mL/m2 increase in LAVI (p<0.01) and a 0.24% 
improvement in global circumferential strain (p<0.01).
Conclusions Our findings highlight the potential positive 
association between the MVPA and light PA on cardiac 
structure and function.
INTRODUCTION
Lack of physical activity (PA) is common in 
the US population, and it is associated with 
multiple detrimental health outcomes.1 
Troubling is the even lower trend of PA in 
Hispanic/Latino men and women. According 
to 2008 report of the National Health Inter-
view Survey, Hispanics/Latinos had lower 
leisure- time PA levels than non- Hispanic 
whites.2 Similarly, 2007–2016 National Health 
and Nutrition Examination Survey (self- 
reported data) indicate that Hispanics/
Latinos are less likely to meet recommended 
Key questions
What is already known about this subject?
 ► Hispanic/Latino are the largest ethnic minority in the 
USA and represent a high- risk population; higher
prevalence of cardiovascular disease factors, rela-
tively understudied population and higher rates of
sedentary behaviour (SB) and lower rates of physi-
cal activity (PA) than other ethnic groups.
What does this study add?
 ► To our knowledge, this is the first study to examine
the association between moderate to vigorous PA
and favourable left ventricle myocardial dynamics,
remodelling, improved right ventricle function with-
out any association with left ventricular mass in a
large cohort of asymptomatic Hispanics/Latinos.
How might this impact on clinical practice?
 ► These findings may allow for more detailed, patient- 
specific, risk- stratification and prognosis in healthy
individuals by gaining insight into the interpretation
of resting echocardiography. This study provides
further evidence that formal recommendations on
limiting SB in persons of varying age should be de-
veloped to provide public health professionals and
clinical practitioners with information to improve
their effectiveness in promoting PA and health.
Physical inactivity should be considered as an im-
portant cardiovascular disease risk factor.
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PA guidelines compared with non- Hispanic whites 
(33.4% vs 47.6%).3
PA is associated with cardiovascular (CV) health 
benefits, including prevention of age- related cardiac 
remodelling, systolic and diastolic dysfunction, adaptive 
pro- hypertrophic effect, decreased markers of inflamma-
tion, improved metabolic health, decreased risk of heart 
failure (HF) and improved overall survival.4–8 Physical 
inactivity is associated with obesity, diabetes, hyperten-
sion and the metabolic syndrome.9–11 All these condi-
tions share several underlying mechanisms that result 
in increased HF risk; insulin resistance, impaired energy 
availability, endothelial dysfunction, oxidative stress, 
which ultimately leads to increased myocardial stiff-
ness, left ventricular (LV) hypertrophy (LVH), diastolic 
dysfunction and an increased propensity for coronary 
artery disease.12–14
A majority of previous epidemiological studies have 
been limited by a lack of objective measures on PA and 
sedentary behaviour (SB). A prior study that used accel-
erometry data only included a large community‐based 
sample of young adults to middle‐aged men and women.6 7 
Additionally, the Hispanic/Latino population is under-
studied, with a limited number of large- scale analyses of 
this population, particularly those that consider the wide 
array of ethnic, cultural and geographic diversity.
Echocardiographic Study of Latinos (ECHO- SOL), 
an ancillary echocardiographic study of the Hispanic 
Community Health Study/Study of Latinos (HCHS/
SOL), is a multicentre epidemiological study designed 
to include a diverse Hispanic/Latino subgroup repre-
sentation and provided a unique opportunity to explore 
the cross- sectional association between accelerometer- 
measured PA, SB, and cardiac structure and function 
as measured by transthoracic echocardiography (TTE). 
This study’s primary aim was to compare echocardio-
graphic measures of cardiac structure and function with 
accelerometer measured PA and SB. We hypothesised 
that higher PA would be favourably associated, and SB 




HCHS/SOL is a prospective population- based longi-
tudinal cohort study (n=16, 415, mean age 43 years) of 
self- identified Hispanic/Latino individuals, 18–74 years 
of age enrolled from 2008 to 2011.15 This study was 
designed to assess chronic disease in Hispanic/Latino 
individuals living in four cities in the USA: Bronx, New 
York; Chicago, Illinois; Miami, Florida; and San Diego, 
California. Participants were recruited in communities 
surrounding four field centres in the respective cities. 
The details of the HCHS/SOL sampling method have 
been previously described.15
ECHO- SOL is an ancillary study of HCHS/SOL 
consisting of 1818 participants recruited through a 
stratified sampling process representative of the parent 
study.16 ECHO- SOL was designed to characterise cardiac 
structure and function using TTE in a representative 
sample of Hispanic/Latino individuals living in the USA. 
The baseline TTE examination for the ECHO- SOL ancil-
lary study was performed from 2011 to 2014.16 Inclusion 
criteria for ECHO- SOL included: age 45 years or older; 
self- reported Hispanic/Latino of Mexican, Puerto Rican, 
Cuban, Dominican, Central American or South American 
background; and enrolment 36 months or fewer from 
the date of the baseline HCHS/SOL visit. ECHO- SOL 
enrolled, on average, ~80% of eligible participants at 
each of the study sites. Inclusion and exclusion criteria 
for ECHO- SOL was previously described.16 17
The current analysis excluded participants who did not 
wear the accelerometer or were not adherent to the accel-
erometer protocol (n=465; at least 3 days with 10 hours 
of wear time each). We excluded those with poor quality 
data on at least one echocardiographic variable (n=39) 
and participants with prior CV disease (CVD) for our 
analysis (n=108). These exclusions yielded an analytic 
sample of n=1206 (66% of participants). The baseline 




The Actical accelerometer (version B-1 model 198-0200-
03; Respironics Co, Bend, Oregon) was used to assess PA 
and SB. The accelerometer data were collected at the 
baseline examination visit. During the HCHS/SOL base-
line clinic visit, participants were fitted with a belt and left 
the clinic wearing the accelerometer above the iliac crest. 
Participants were instructed to perform normal daily 
activities and wear the accelerometer only during awake 
hours and remove it for sleep, showering and swimming. 
The Actical device was programmed to measure acceler-
ations in counts per 1 min epochs based on the conven-
tion used in previous studies.18 The time used for analysis 
started at 05:00 the morning after the initial clinic visit 
and ended at midnight on the sixth day of wear. Non- 
wear was defined as consecutive zero counts for at least 
90 min.18 PA threshold levels were defined as follows: SB 
<100 counts/min, light 100–1534 counts/min, moderate 
1535–3961 counts/min and vigorous ≥3962 counts/
min.19 20 For the present analysis, data for moderate to 
vigorous PA (MVPA) were combined, denoted as MVPA, 
because very few people had a significant amount of 
vigorous activity. Adherence and accelerometer perfor-
mance have been previously described.18 Adherence was 
defined as ≥10 hours/day of wear time for at least 3 days 
of wear. Time spent in PA by intensity level was calcu-
lated by summing the minutes in a day where the counts 
were within each threshold and then averaging across 
adherent days.
The HCHS/SOL assessed self- reported PA in a typical 
week using an interviewer- administered, modified Global 
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PA Questionnaire that included questions on three 
activity domains (work, transport and leisure) available at 
www. int/ chp/ steps/ GPAQ/ en. Participants were asked 
to think about activities that lasted at least 10 min in a 
typical week. We only included accelerometer- measured 
PA for our analysis.
Echocardiography measures
The average time between the accelerometer data 
and echocardiographic measures was 815±196 days. A 
complete description of the echocardiographic meas-
ures of cardiac structure and function was previously 
reported.16 17 21 Briefly, a standardised TTE ultrasound 
examination, including M- mode, two- dimensional, spec-
tral, colour flow and tissue Doppler, was performed by 
experienced Registered Diagnostic Cardiac Sonographers 
at each of the four parent study field sites using Philips 
IE-33 or Sonos 7500 scanners interfaced with a standard 
2.5–3.5 MHz phased- array probe, according to American 
Society of Echocardiography (ASE) recommendations.22 
Echocardiograms were analysed and interpreted centrally 
at Wake Forest School of Medicine (Winston- Salem, 
North Carolina, USA). Inter- reader and intra- reader 
reproducibility was assessed and previously reported.16 
Two- dimensional imaging of the LV was performed to 
obtain the best possible images of the LV endocardium 
without foreshortening of the LV cavity or echo drop out. 
Using the apical 4- chamber and 2- chamber views, LV end- 
diastolic volumes (EDV) and end- systolic volumes (ESV) 
were derived using the biplane method of discs, as per 
the ASE recommended methodology.22 The following 
echocardiographic measured and derived variables were 
used: LV mass (LVM) was determined by subtracting the 
LV endocardial cavity volume from the LV epicardial 
volume and multiplying the resultant myocardial volume 
by the myocardial density (1.05 g/mL) then indexing 
based on the body surface area or height2.7. LV geometry 
was predicated on the measurement of LVM, LV poste-
rior wall thickness at diastole (LVPWd), interventricular 
septal thickness at diastole and relative wall thickness 
(RWT) defined as 2×(LVPWd/LV internal diameter at 
diastole). LV geometry was defined as normal (normal 
LVM and normal RWT) or abnormal with abnormal LV 
geometry categorised as follows: concentric remodelling 
(normal LVM and increased RWT), eccentric hyper-
trophy (increased LVM and normal RWT) and concen-
tric hypertrophy (increased LVM and increased RWT).22 
LV ejection fraction (LVEF)=(EDV−ESV)/EDV. LVEF 
could not be ascertained in 4.9% of the cohort because 
of image quality. Our assessment of LV diastolic dysfunc-
tion (LVDD) has been previously published.21 Right 
ventricular (RV) systolic function and tricuspid valve 
regurgitation velocity (TRV) were assessed according 
to ASE guidelines. Speckle- tracking strain analysis was 
performed offline using the TomTec Cardiac Perfor-
mance Analysis package on two- dimensional images 
acquired, and methods were previously described.16
Primary structural and functional measures included LVM 
indexed to height2.7 (LVMI), RWT, left atrial volume (LAV), 
LAV index (LAVI) and EF, mid- LV segment global circum-
ferential strain (GCS), global longitudinal strain (GLS) 
and LV diastolic functional measures. Secondary cardiac 
measures included LV stroke volume (LVSV), lateral peak 
systolic annular velocity (lat peak S’), RV fractional area 
change (RV FAC), TRV, tricuspid annulus systolic velocity 
(RV S’ wave), RV velocity- time integral (RV VTI), RVSV and 
tricuspid annular plane systolic excursion (TAPSE).
Clinical covariates
All measures were taken from the baseline visit (2008–
2011). Trained technicians measured each participant’s 
height and weight twice and then averaged these two 
measures to calculate body mass index (BMI=weight 
(kg)/height (m2)). Participants with a BMI of ≥30 kg/
m2 were categorised as obese. Three seated blood pres-
sure (BP) measures were taken using an automatic 
sphygmomanometer averaging the last two measures. 
Hypertension was defined as a systolic BP of 140 mm 
Hg or greater, diastolic BP of 90 mm Hg or greater, or 
receiving antihypertensive medication. Participants were 
classified as having hypercholesterolaemia if they were 
currently using the cholesterol- lowering medication, 
had low- density lipoprotein levels ≥160 mg/dL, or total 
cholesterol ≥240 mg/dL. Total and high- density lipo-
protein (HDL) cholesterol was measured with a direct 
magnesium/dextran sulfate method. Plasma glucose 
was measure fasting and after a 2- hour glucose load. 
Diabetes mellitus was a fasting plasma glucose of 126 mg/
dL or greater, 2- hour- post load glucose of 200 mg/dL 
or greater, glycosylated haemoglobin 6.5% or greater, 
or use of antihyperglycaemic medications. Self- reported 
current smoking history referring to cigarette smoking 
and current alcohol intake referring to alcohol history 
was collected via questionnaire.23
Healthy subgroup (n=460) was defined as not 
having hypertension (systolic BP≥140 mm Hg, diastolic 
BP≥80 mm Hg or history of drug- treated hypertension), 
diabetes (history of a diagnosis of diabetes mellitus, 
fasting glucose≥126 mg/dL or glycosylated haemo-
globin≥6.5%), coronary heart disease (self- reported 
history of revascularisation, myocardial infarction, angina 
or ECG defined evidence of myocardial infarction) or 
obesity (BMI≥30 kg/m2).
Statistical methods
The primary aim of this study was to compare echocardi-
ographic measures of cardiac structure and function in 
participants with higher levels of PA and SB. The dependent 
variables were echocardiographic measures of cardiac struc-
ture and function. SB, light PA and MVPA were the primary 
independent variables. Cohort characteristics at baseline 
were described using means and SEs for continuous varia-
bles and frequencies (percentages) for categorical variables. 
SB, light PA and MVPA, and all echocardiographic meas-
ures were treated as continuous variables.
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Hypertension, diabetes and current cigarette smoking 
were treated as categorical variables. The means of echo-
cardiographic measures of cardiac structure and func-
tion were compared across categories of PA (MVPA, light 
PA) and SB using multivariable linear regression models. 
Age, sex, hypertension, antihypertensive medications, 
diabetes, current cigarette smoking and HDL cholesterol 
were included as covariates in the analysis. Covariates 
were chosen based on known associations with ventric-
ular size and heart disease, including demographics and 
anthropometric variables, and variables reflecting comor-
bidities. Model 1—demographics, model 2—model 1 plus 
continuous systolic BP and antihypertension medication 
use, model 3—model 2 plus other CV disease modifiable 
factors (diabetes mellitus, current smoking and contin-
uous HDL). We divided the light PA, MVPA and SB into 
quartiles (Q1–Q4) and compared the echocardiographic 
variables between the highest quartile (Q4) to other 
quartiles by univariate analysis.
Estimated beta coefficients and p values based on the F 
statistic were presented. Statistical significance was desig-
nated as a p value ≤0.01 with no adjustments for multiple 
comparisons. SAS SURVEY procedures were used, and 
all reported values were weighted to adjust for sampling 
probability and non- response bias to make the inference 
applicable to the ECHO- SOL target population. All anal-
yses were performed using SAS V.9.4 (SAS Institute).
RESULTS
Baseline characteristics of the study population are 
provided in table 1. The mean age of included partici-
pants was 56 years; 57% were women, 28% had diabetes, 
50% had hypertension and 18% reported current ciga-
rette smoking. On average, participants accumulated 
(mean±SD) 21±1.1 min/day of MVPA; 217±4.2 min/
day of light PA and 737±8.1 min/day of SB. Men accu-
mulated more MVPA compared with women (27±1.6 vs 
17±1.3 min/day, p<0.001) (figure 1). Participants aged 
>65 years had less MVPA accumulation than participants
aged <55 years (17±3.0 vs 24±1.5, p=0.03). Overall, partic-
ipants aged >55 years spent less time in both light PA and 
MVPA than those less than 55 years of age (figure 2). 
Online supplemental table 1 shows the prevalent self- 
reported PA in ECHO/SOL.
Associations between PA and echocardiographic measures
Light PA
Compared with less light PA time (quartile 1), more light PA 
(quartile 4) was associated with decreased LVMI/ EDV ratio 
(p<0.001) and a decrease in E/e′ ratio (p<0.001) (online 
supplemental table 2). In multivariable linear regression 
models between light PA and echocardiographic measures 
(model 3), every 10 min/day of light PA was associated with 
a 0.03 mL/m2 increase in LAVI (p<0.01) and a 0.004 cm 
increase in TAPSE (p<0.01). There were no statistically 
significant associations between light PA and other echocar-
diographic measures (table 2).
Moderate to vigorous PA
Compared with less MVPA (quartile 1), greater MVPA 
(quartile 4) was associated with decreased LVMI/EDV 
ratio (p<0.001), increased LAVI (p<0.001) and decrease 
in E/e′ (p<0.001) ratio (online supplemental table 
3). In a multivariable linear regression model between 
PA and echocardiographic measures (model 3), every 




Body mass index (kg/m2) 30.1 (0.1)
Body surface area (m2) 1.8 (0.1)
Systolic BP, mm Hg 136 (1.0)
Diastolic BP, mm Hg 78 (0.7)
Diabetes, % 343 (28)
Hypertension, % 603 (50)
Hypercholesterolaemia, % 626 (49)
HDL cholesterol, mg/dL 50.4 (0.7)
Alcohol use, % 903 (75)
Current cigarette smoking, % 212 (18)
Echocardiographic measurements
Left ventricular mass index (LVMI, g/m2.7) 41.5 (0.35)
Relative wall thickness, ratio 0.40 (0.003)
LVMI2.7/end- diastolic volume 0.52 (0.006)
Left atrial volume index, mL/m2 23.02 (0.25)
Left ventricular ejection fraction, % 59.80 (0.20)
E/e′, ratio 9.96 (0.12)
Global longitudinal strain, % −17.56 (0.13)
Global circumferential strain, % −24.33 (0.29)
LV stroke volume, mL 70.30 (0.61)
Lateral peak S velocity, cm/s 8.30 (0.08)
RV peak S velocity, cm/s 11.88 (0.09)
RV fractional area change, % 0.45 (0.004)
TR max velocity, cm/s 206.35 (1.69)
RV velocity- time integral, cm 17.42 (0.15)
TAPSE, cm 2.09 (0.02)
Physical activity and sedentary behaviour
MVPA, min/day 20.93±1.1
Light PA, min/day 216.84±4.2
Sedentary behaviour, min/day 736.50±8.1
N (%) using weighted row percentages; N’s presented are 
weighted counts.
Data presented in means±SE of mean.
BP, blood pressure; E, peak early diastolic transmitral inflow 
velocities; e′, average of mitral early diastolic septal and 
lateral annular velocities; HDL, high- density lipoprotein; LV, left 
ventricular; MVPA, moderate to vigorous- intensity PA; n, number; 
PA, physical activity; RV, right ventricular; TAPSE, tricuspid annular 
plane systolic excursion; TR, tricuspid regurgitation.
5Berdy AE, et al. Open Heart 2021;8:e001647. doi:10.1136/openhrt-2021-001647
Health care delivery, economics and global health care
10 min/day of MVPA was associated with a 0.18 mL/m2 
increase in LAVI (p<0.01) and a 0.24% improvement 
in GCS (p<0.01). No statistically significant associations 
were noted between MVPA and other echocardiographic 
measures (table 3).
SB and echocardiographic measures
Compared with lower SB (quartile 1), higher SB (quartile 
4) was associated with increased LVMI (p=0.008) (online
supplemental table 4). In multivariable linear regression
models between SB and echocardiographic measures
(model 3), there were no statistically significant asso-
ciations between SB and any of the echocardiographic
measures (table 4). Online supplemental table 5 shows
an unadjusted association between PA and echocardio-
graphic measures.
PA and echocardiographic measures in healthy subgroup
In a multivariable linear regression model between 
PA and echocardiographic measures (model 3), both 
MVPA and light PA was associated with increased LAVI, 
improved GLS, improved E/e ratio, improved RV 
function (increase in TAPSE); MVPA was associated 
with greater SV (online supplemental table 6). SB was 
associated with worsening E/e, GLS and RV function 
(decrease in TAPSE). SB was negatively correlated with 
SV.
We performed additional analysis to find the correla-
tion between MVPA and SB. The correlation between 
sedentary time and MVPA is very weak with a Pearson 
correlation coefficient of −0.1 (p=0.26) and a very flat 
slope on the scatterplot of the two variables.
DISCUSSION
In this large cohort of diverse Hispanic/Latinos, we 
found that higher light PA was associated with increased 
LAV and better RV systolic function after adjustment for 
potential confounders. Similarly, higher MVPA was asso-
ciated with greater LV myocardial mechanics as assessed 
by strain and increased LAV. Both higher levels of light 
PA and MVPA (min/day) were associated with decreased 
LVMI/EDV, indicative of favourable LV remodelling and 
decrease E/e′ ratio, a sign of decrease LA pressure. Higher 
levels of SB were associated with increased LVM. In the 
healthy subgroup, both MVPA and light PA were associ-
ated with greater LV myocardial mechanics, decrease LA 
pressure, and better RV function. SB was associated with 
Figure 1 Physical activity and sedentary behaviour by 
gender. *Data presented in means±SE of mean. The number 
above the bar shows mean activity in min/day. MVPA, 
moderate to vigorous- intensity PA; PA, physical activity.
Figure 2 Physical activity and sedentary behaviour by age. 
Data presented in means±SE of mean. The number above 
the bar shows mean activity in min/day. MVPA, moderate to 
vigorous- intensity PA; PA, physical activity.
Table 2 Multivariable linear regression for the association 
between light PA and echocardiogram parameters
Outcome Model 1 Model 2 Model 3
LVMI, g/m2.7 −0.02882 −0.00597 0.01003
LVMI2.7/EDV −0.00157 −0.00135 −0.00108
RWT, ratio 0.00014 0.00021 0.00030
LAVI, mL/m2 0.02431* 0.03206* 0.02840*
EF, % 0.01336 0.01369 0.00728
E/e′, ratio −0.00843 −0.00521 0.00086
GLS, % −0.02085 −0.01784 −0.01333
GCS, % −0.02332 −0.02139 −0.01778
SV, mL −0.02847 −0.03209 −0.03206
RV peak S, cm/s 0.01126 0.01249 0.01287
RV FAC, % 0.00048 0.00051 0.00034
TRV Max, cm/s 0.20262 0.18327 0.13431
TAPSE, cm 0.0037* 0.0040* 0.0037*
M1: demographics (age and sex).
M2: M1+systolic blood pressure, antihypertensive medication use.
M3: M2+other cardiovascular disease modifiable factors (diabetes 
mellitus, current smoking and continuous high- density lipoprotein).
Values are per 10 min/day light PA.
*P value <0.01.
E, peak early diastolic transmitral inflow velocities; EDV, end 
diastolic volume; e′, average of mitral early diastolic septal 
and lateral annular velocities; EF, ejection fraction; GCS, global 
circumferential strain; GLS, global longitudinal strain; LAVI, left 
atrial volume index; LVMI, left ventricular mass index; M, model; 
PA, physical activity; RV, right ventricular; RV FAC, RV fractional 
area change; RWT, relative valve thickness; SV, stroke vol; 
TAPSE, tricuspid annular plane systolic excursion; TRV, tricuspid 
regurgitation velocity.
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worsening LV myocardial mechanics, worsening LA pres-
sure, and RV function.
Although increased PA has been associated with higher 
LVM, LA size and LV EDV in multiple prior studies,5 7 24 25 
to our knowledge, this is the first study to examine the 
association between accelerometry measured MVPA and 
improved LV myocardial mechanics. While there was 
no clinically significant association between LVEF and 
MVPA, LV GCS was significantly more favourable with 
MVPA. GCS reflects the change in length around the LV 
perimeter during systole as the myocardium shortens and 
the LV cavity circumference reduces. During incremental 
dynamic aerobic exercise, studies reported a progressive 
increase in GCS due to increased apical circumferential 
strain (ACS) with trivial effects on basal circumferential 
strain (BCS).26 In contrast, GCS decreased during the 
isometric exercise with no effect on ACS and decreased 
BCS from rest.26 Therefore, exercise modality plays some 
role in GCS responses, and we did not have a granular 
breakdown of PA type. Further studies of global and 
region- specific circumferential strain during incremental 
exercise are lacking at present, and GCS responses 
during dynamic and static modalities remain incom-
pletely understood.
Light PA was associated with better RV systolic function. 
Besides, higher quartiles of MVPA were also associated 
with better RV systolic function. Although these findings’ 
implications are unclear, even small absolute changes in 
the very thin- walled RV in disease- free participants may 
have significant long- term effects. Aaron et al found that 
higher levels of both MVPA and intentional exercise were 
associated with larger RV stroke volume without a change 
in RVEF.27 Recent studies of patients with pulmonary 
arterial hypertension have shown that exercise training 
is safe and can improve exercise endurance, 6 min walk 
distance and quality of life.28 Recently, it has been noted 
that higher cardiorespiratory fitness (CRF) was associ-
ated with improved RV systolic function (TAPSE, RV S’ 
wave).29 In addition, less decline in PA over time was 
associated with better RV systolic function. Structural and 
functional LV abnormalities may contribute to abnormal-
ities in RV function. LV systolic or diastolic dysfunction 
leads to elevated LV end‐diastolic pressure, which may 
cause pulmonary venous hypertension and high pulmo-
nary artery systolic pressure, and RV systolic dysfunction. 
In addition, HF risk factors can adversely affect both 
RV and LV function such that subclinical abnormali-
ties in RV function may precede and contribute to the 
Table 3 Multivariable linear regression for the association 
between MVPA and echocardiogram measures
Outcome Model 1 Model 2 Model 3
LVMI, g/m2 0.0411 0.1318 0.1381
LVMI2.7/EDV −0.0014 −0.0006 −0.0006
RWT, ratio −0.0005 −0.0001 0.0001
LAVI, mL/m2 0.1707* 0.1808* 0.1792*
EF, % 0.0578 0.0448 0.0389
E/e′, ratio 0.0037 0.0221 0.0259
GLS, % −0.069 −0.0521 −0.0539
GCS, % −0.2477* −0.2397* −0.2397*
SV, mL 0.3277 0.3177 0.3174
RV peak S, cm/s 0.0589 0.0590 0.0615
RV FAC, % 0.0021 0.0019 0.0019
TRV Max, cm/s 1.1367 1.1386 1.1597
TAPSE, cm 0.0084 0.0082 0.0078
M1: demographics (age and sex).
M2: M1+systolic blood pressure, antihypertensive med use.
M3: M2+other cardiovascular disease modifiable factors (diabetes 
mellitus, current smoking and high- density lipoprotein).
Values are per 10 min/day light MVPA.
*P value <0.01.
E, peak early diastolic transmitral inflow velocities; EDV, end 
diastolic volume; e′, average of mitral early diastolic septal 
and lateral annular velocities; EF, ejection fraction; GCS, global 
circumferential strain; GLS, global longitudinal strain; LAVI, left 
atrial volume index; LVMI, left ventricular mass index; M, model; 
MVPA, moderate to vigorous PA; RV, right ventricular; RV FAC, RV 
fractional area change; RWT, relative valve thickness; SV, stroke 
volume; TAPSE, tricuspid annular plane systolic excursion; TRV, 
tricuspid regurgitation velocity.
Table 4 Multivariable linear regression for the association 
between sedentary behaviour and echocardiogram 
measures
Outcome Model 1 Model 2 Model 3
LVMI, g/m2.7 0.0626* 0.0485 0.0433
LVMI2.7/EDV 0.0008 0.0006 0.0005
RWT, ratio 0.0000 −0.0002 0.0000
LAVI, mL/m2 −0.0066 −0.0066 −0.0035
EF, % −0.0025 −0.0005 0.0025
E/e′, ratio 0.0144 −0.0074 −0.0341
GLS, % 0.0041 0.0035 0.0014
GCS, % −0.0377 −0.0390 −0.0413
SV, mL 0.0073 −0.0039 0.0001
RV peak S, cm/s 0.0090 0.0075 0.0068
RV FAC 0.0001 0.0001 0.0002
TRV max, cm/s −0.0457 −0.0459 −0.0330
TAPSE, cm −0.0010 −0.0011 −0.0010
M1: demographics (age and sex).
M2: M1+systolic blood pressure, antihypertensive med use.
M3: M2+other cardiovascular disease modifiable factors (diabetes 
mellitus, current smoking and high- density lipoprotein).
Values are per 10 min/day of sedentary behaviour.
*P value <0.01.
E, peak early diastolic transmitral inflow velocities; EDV, end 
diastolic volume; e′, average of mitral early diastolic septal 
and lateral annular velocities; EF, ejection fraction; GCS, global 
circumferential strain; GLS, global longitudinal strain; LAVI, left 
atrial volume index; LVMI, left ventricular mass index; M, model; 
RV, right ventricular; RV FAC, RV fractional area change; RWT, 
relative valve thickness; SV, stroke vol; TAPSE, tricuspid annular 
plane systolic excursion; TRV, tricuspid regurgitation velocity.
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development of HF, especially in HFpEF. Taken together, 
such exercise- induced adaptive changes in RV may be 
beneficial with potentially important implications for 
diseases characterised by pulmonary hypertension and 
RV dysfunction. These data may be useful in studying the 
RV- specific benefits of exercise in at- risk populations.
Increases in LA size associated with higher CV fitness 
and MVPA have been described.4–7 In the general popu-
lation, however, increased LA size is associated with many 
pathological conditions, and it is usually the result of two 
processes, either increased volume or increased cardiac 
filling pressures. Interestingly, similar to our findings, the 
Cooper Clinic Longitudinal study observed no apparent 
association between diastolic dysfunction and LA size 
among high- fit individuals.4 Our findings and those 
reported by others suggest that LA dilation mechanisms 
may reflect physiology unrelated to diastolic function (ie, 
greater cardiac output) with higher PA.4–7
Recently Dallas Heart Study, which included 1368 partic-
ipants (age, 49 years; 40% men, free of CVD), showed 
that objective measures of MVPA (assessed by acceler-
ometer) were positively associated with more favourable 
LV structure and function parameters (assessed cardiac 
MRI), with better LV contractility, higher SV, lower arte-
rial elastance, and LVH without myocardial injury, inde-
pendent of traditional CVD risk factors.7 Vigorous PA was 
also positively associated with higher SV and lower effec-
tive arterial elastance measures and greater likelihood of 
both LVH without myocardial injury and malignant LVH. 
The moderate PA levels and SB were not associated with 
LV structure and function in the most adjusted analysis. 
Higher quartiles of MVPA and light PA were associated 
with favourable LV remodelling and improved diastolic 
function.
Improved diastolic function, increased LA size, 
improved LV mechanics (GCS), and RV systolic func-
tion further support that physiological adaptation with 
increased cardiac size characterised by normal cardiac 
morphology with a normal and enhanced cardiac func-
tion. This is similar to the recent Cooper Clinic Longi-
tudinal study, which showed that higher cardiac fitness 
levels were independently associated with increased LA 
size, LV internal diameter at diastole, and decreased 
RWT and decreased E/e′.4 Similar to our study, there was 
no positive association between higher fitness and LVMI. 
This evidence taken together with our study confirms that 
staying active is more strongly associated with favourable 
measures of cardiac structure and function even at the 
level of light PA. Our improved LV strain, LV remodelling, 
LA volume, and improved diastolic function align with 
Dallas heart study results.7 These results further support 
the physiological benefits of long‐term aerobic exercise 
and PA on cardiac structure and function. Importantly 
prior study also showed that only MVPA but not sedentary 
time were significantly associated with CRF levels.
While LVM, RV mass, LV volumes tend to decrease 
with bed rest or deconditioning.30 The chronic conse-
quences of SB (increased obesity or obesity- related 
comorbidities, diabetes and hypertension) are generally 
associated with increased LVM and worse cardiac func-
tion.31–33 Thus, it is unclear whether and in which direc-
tion SB would be related to LV structure and function 
independently of PA, obesity and obesity- related comor-
bidities. A recent community- based study that included 
middle- aged adults free from overt clinical CV disease 
found that higher sedentary screen time was associated 
with increased LVMI, mass- to- volume ratio and RWT in 
Caucasians but not African Americans.34 Similarly, low 
fitness was independently associated with smaller heart 
size and concentric remodelling patterns in the Cooper 
Clinic Longitudinal Study.4
Taken together from ours and other studies, it has been 
noted that PA or higher CRF was associated with greater LV 
myocardial mechanics (LV strain), decreased LVMI/EDV 
(indicative of favourable LV remodelling), decrease E/e′ 
ratio (a sign of decrease LA pressure), improved myocar-
dial mechanics, lower arterial stiffness and improved RV 
function, which further supports the role of long- term 
aerobic exercise in preventing HF.29 35–37 Besides, SB has 
been associated with higher HF risk and a greater burden 
of abnormalities in LV structure. Furthermore, low CRF 
also explained up to 40% of HF’s high body mass index 
associated risk.35 This is very important with HFpEF since 
there is no proven benefit with pharmacological therapy 
in HFpEF except exercise training and calorie restriction 
and obesity is parallel with the HFpEF epidemic.38 While 
there is a large base of data that supports the CV bene-
fits of PA and the detrimental effect of SB, these effects 
are broad and pleiotropic. PA is associated with various 
CV health benefits; decrease in BP, improved metabolic 
health, improved vascular function, decrease vascular 
stiffness, improved endothelial function, prevention of 
age- related cardiac remodelling, systolic and diastolic 
dysfunction, and adaptive pro- hypertrophic effect.4–7 39 40
It is hypothesised that improved vascular function is 
due to reduced oxidative stress and subsequent improved 
endothelial dysfunction from PA. A separate study 
demonstrated that exercise could return the expected 
age- associated vascular tone to a more vasodilated state 
equivalent to that of younger subjects.40
Strength and limitations
The sizeable community- based sample, comprehensive 
assessment of PA (including SB and light PA) and echo-
cardiographic measurements (including diastolic func-
tion, strain analysis, RV function) strengthen our inves-
tigations. Our study is also unique since this included an 
understudied high- risk population with a high prevalence 
of CV disease, risk factors and comorbidities. Most prior 
studies rely on the self- reported assessment of PA and SB. 
Using accelerometers to objectively quantify PA and SB 
reduces measurement error and allows for a more precise 
categorisation of the degree and amount of PA and SB.
Nonetheless, several limitations merit comment. The 
cross- sectional nature of this analysis prevents any causal 
inferences. Although we adjusted all models for multiple 
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variables, the influence of residual confounding cannot 
be excluded. The accelerometry data were obtained prior 
to echocardiography, and that can result in underesti-
mating the strength of the associations between MVPA 
and cardiac measurements (regression dilution bias). 
The hip- worn accelerometer is likely to underestimate 
certain activities such as bicycling and swimming (since 
they removed it when in the water). Additionally, accel-
erometry was assessed for only 1 week. While this is stan-
dard in the field,41 and others have shown it may reflect 
longer- term patterns of PA and SB among women,42 a 
longer measurement period would be an improvement.
Here we chose not to adjust the p value for multiple 
comparisons because each outcome was selected based 
on a priori hypothesis and a unique mechanism between 
exposure and each cardiac parameter. We were inter-
ested in controlling the type I error rate per the outcome 
of interest rather than per group of outcome variables. 
We only rejected the null hypothesis with a conservative 
p value of less than 0.01. Nevertheless, the results should 
be interpreted cautiously and validated in other studies. 
Several of our findings may be considered hypothesis- 
generating and warrant replication in subsequent studies. 
The sample size of ECHO- SOL is modest, limiting type II 
error. The type of PA (weight- training, cardio or isometric) 
may influence a different cardiac response (with GCS or 
other parameters). We did not have a PA- type breakdown 
for accelerometry data. Besides, accelerometry does not 
capture resistance training.
CONCLUSION
In a community- based population with multiple risk 
factors for developing LV dysfunction, both MVPA 
and light PA were associated with favourable cardiac 
mechanics after adjusting for major CV risk factors. 
Future studies of PA and cardiac function with a larger 
sample and a prospective longitudinal design are needed 
to assess cardiac function with clinical outcomes better.
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Supplemental Table 1. Prevalent self-reported physical activity in ECHO SOL 
Activity Prevalence 
















Coaching sports  
Light cycling 
Weight lifting  
Swimming laps  
Table tennis 
Rock climbing  
Skating 
Hunting/Fishing 
Karate/Judo/Other Martial arts 
Frisbee play 




























All proportions are weighted to account for the survey design 
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Supplemental Table 2.  Echocardiographic measures with quartiles of light PA 









Q4 vs. Q1 
p value 
Q4 vs. Q2 
LVMI, g/m2.7 42.5±0.9 41.7±0.80 41.7±0.68 40.7±0.58 0.081 0.300 
LVMI2.7/ EDV 0.58±0.02 0.53±0.01 0.51±0.01 0.49±0.01 < 0.001 0.050 
RWT, ratio 0.40±0.00 0.40±0.00 0.39±0.00 0.40±0.00 0.456 0.530 
LAVI, ml/m2 22.6±0.21 23.3±0.24 23.9±0.19 23.0±0.15 0.090 0.200 
EF, % 60.0±0.34 59.7±0.34 59.9±0.39 59.8 ±0.33 0.673 0.700 
E/e’, ratio 10.6±0.2 9.6±0.2 9.6±0.2 9.5±0.2 <0.001 0.760 
GLS, % -17.3±0.24 -17.5±0.19 -17.3±0.19 -18.1±0.27 0.012 0.064 
GCS, % -24.0±0.53 -24.4±0.41 -23.7±0.51 -25.0±12.3 0.135 0.280 
RV peak S, cm/sec 11.6±0.15 11.8±0.18 12.0±0.16 12.3± 0.19 0.010 0.050 
TAPSE, cm 17.2±0.21 17.1±0.27 17.2±0.20 17.7±0.41 0.223 0.262 
RV FAC, % 0.44±0.00 0.45±0.00 0.45±0.00 0.45±0.00 0.287 0.870 
TRV Max, cm/sec 211.3±3.2 204.0±3.3 203.1±2.6 207.7±3.2 0.427 0.422 
*Data presented in means +/- standard errors of mean
PA =physical activity, Q=quartile, LVMI =left ventricular mass index, EDV=end diastolic volume, 
RWT=relative valve thickness, LAVI=left atrial volume index, EF=ejection fraction, E =peak early 
diastolic transmitral inflow velocities, e’ =average of mitral early diastolic septal and lateral 
annular velocities, GLS =global longitudinal strain, GCS = global circumferential strain, RV=right 
ventricular, RVFAC= RV fractional area change, TAPSE = tricuspid annular plane systolic 
excursion; TRV= tricuspid regurgitation velocity. 
p value is calculated based on quartile 4 to other quartiles 
p ≤ 0.01 considered significant 
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Supplemental table 3. Echocardiographic measures with quartiles of MVPA 













LVMI, g/m2.7 43.8±0.80 41.7±0.88 41.0±0.68 41.2±0.62 0.127 0.688 
LVMI2.7/ EDV 0.58±0.02 0.54±0.01 0.51±0.01 0.48±0.01 < 0.001 0.001 
RWT, ratio 0.41±0.00 0.40±0.00 0.40±0.00 0.39±0.00 0.031 0.150 
LAVI, ml/m2 22.7±0.2 22.8±0.2 23±0.2 24.2±0.2 < 0.001 < 0.001 
EF, % 60.1±0.36 59.6±0.51 60.3±0.34 59.5±0.40 0.248 0.888 
E/e’, ratio 10.6±0.2 10.1±0.2 9.4±0.2 9.4±0.2 < 0.001 0.005 
GLS, % -17.6±0.24 -17.3±0.21 -17.8±0.21 -17.6±0.28 0.868 0.300 
GCS, % -23.4±0.6 23.7± 0.4 -24.9± 0.4 25.2 ±0.6 0.010 0.024 
RV peak S, cm/sec 11.6±0.18 11.6±0.15 12.1± 0.15 12.2± 0.17 0.010 0.003 
TAPSE, cm 17.5±0.24 17.2±0.24 17.1±0.22 17.5±0.42 0.983 0.642 
RV FAC, % 0.44±0.01 0.44±0.00 0.45±0.00 0.46±0.00 0.033 0.031 
TRV Max, cm/sec 209.1±3.6 208.6±3.4 206.±0 2.6 208.6±3.5 0.920 0.211 
*Data presented in means +/- standard errors of mean
MVPA = moderate to vigorous-intensity physical activity; Q=quartile, LVMI =left ventricular mass 
index, EDV=end diastolic volume, RWT=relative valve thickness, LAVI=left atrial volume index, 
EF=ejection fraction, E =peak early diastolic transmitral inflow velocities, e’ =average of mitral 
early diastolic septal and lateral annular velocities, GLS =global longitudinal strain, GCS = 
global circumferential strain, RV=right ventricular, RVFAC= RV fractional area change, TAPSE 
= tricuspid annular plane systolic excursion; TRV= tricuspid regurgitation velocity. 
p value is calculated based on quartile 4 to other quartiles 
p ≤ 0.01 considered significant 
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Supplemental Table 4. Echocardiographic measures with quartiles of sedentary behavior 






Q4: > 884 
min/day 
p value 
Q4 vs. Q1 
p value 
Q4 vs. Q2 
LVMI, g/m2.7 41±0.6 40.4±0.6 41.8±0.7 44.0±0.9 0.008 0.002 
LVMI2.7/ EDV 0.52±0.01 0.51±0.01 0.53±0.01 0.56±0.01 0.029 0.020 
RWT, ratio 0.40±0.00 0.40±0.00 0.40±0.00 0.40±0.00 0.314 0.530 
LAVI, ml/m2 23.5±0.6 23.1±0.19 22.9±0.23 23.2±0.3 0.381 0.851 
EF, % 59.8±0.49 59.7±0.36 60.1±0.34 60.0±0.32 0.804 0.552 
E/e’, ratio 9.6±0.23 10.0±0.18 9.9±0.19 10.0±0.16 0.117 0.837 
GLS, % -17.5±0.25 -17.6±0.26 -17.6±0.21 -17.3±0.18 0.620 0.476 
GCS, % -23.4±0.51 -24.1±0.62 -24.8± 0.40 -25.1±0.51 0.010 0.190 
RV peak S, cm/sec 11.5±0.17 11.8±0.19 12.3±0.16 12.0±0.19 0.080 0.364 
TAPSE, cm 17.5±0.19 17.6±0.37 17.4±0.23 16.6±0.26 0.022 0.042 
RV FAC, % 0.44±0.00 0.45±0.00 0.46±0.00 0.45±0.00 0.357 0.780 
TRV Max, cm/sec 205.4±2.4 211.2±3.3 203.5±3.2 205.5±3.6 0.984 0.255 
*Data presented in means +/- standard errors of mean
Q=quartile, LVMI =left ventricular mass index, EDV=end diastolic volume, RWT=relative valve 
thickness, LAVI=left atrial volume index, EF=ejection fraction, E =peak early diastolic transmitral 
inflow velocities, e’ =average of mitral early diastolic septal and lateral annular velocities, GLS
=global longitudinal strain, GCS = global circumferential strain, RV=right ventricular, RVFAC= 
RV fractional area change, TAPSE = tricuspid annular plane systolic excursion; TRV= tricuspid 
regurgitation velocity. 
p value is calculated based on quartile 4 to other quartiles 
p ≤ 0.01 considered significant 
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Supplemental Table 5. Unadjusted Associations Between Physical Activity and Echocardiographic 
Measures 
Sedentary time/day MVPA/day Light PA/day 
Estimate p-value Estimate p-value Estimate p-value
LVMI, g/m2.7 0.0721 0.003 -0.0002 0.999 -0.0892 0.012 
RWT 0.0001 0.367 -0.0013 0.291 -0.0004 0.172 
LVMI2.7/EDV 0.0011 0.004 -0.0007 0.005 -0.0033 <0.001 
LAVI -0.0042 0.481 0.1568 <0.001 0.0081 0.334 
EF % 0.0003 0.973 -0.0200 0.810 -0.0057 0.748 
E/e’ 0.0065 0.268 -0.0696 0.244 -0.0396 <0.001 
GLS, % 0.0006 0.345 -0.0279 0.494 -0.0280 0.023 
GCS, % -0.0350 0.011 -0.2244 0.015 -0.0348 0.242 
SV, ml 0.0086 0.842 0.6841 0.093 -0.0165 0.812 
Lat peak S  -0.0028 0.596 0.0271 0.257 0.0092 0.248 
RV peak S 0.0072 0.136 0.0893 0.005 0.0211 0.016 
RV FAC 0.0001 0.600 0.0017 0.125 0.0004 0.185 
TRV, cm/sec 0.0004 0.959 0.3446 0.507 -0.1817 0.311 
RV VTI -0.0196 0.005 0.0088 0.861 0.0256 0.158 
TAPSE, cm 
-0.0012 0.137 0.0121 0.026 0.0045 
<0.001 
*p-value <0.01 considered significant
Values are per 10 min/day of PA
LVMI =left ventricular mass index, RWT=relative valve thickness, EDV=end diastolic volume, LAVI=left atrial volume index, EF=ejection fraction, E 
=peak early diastolic transmitral inflow velocities, e’ =average of mitral early diastolic septal and lateral annular velocities, LS =global longitudinal
strain, GLS =global longitudinal strain, GLS = global circumferential strain, SV =stroke volume, RV=right ventricular, RVFAC= RV fractional area 
change, TR= tricuspid regurgitation, TAPSE = tricuspid annular plane systolic excursion, MVPA = moderate to vigorous-intensity PA, PA= physical 
activity 
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Supplemental Table 6:   Multivariable Linear Regression for the Association between MVPA, Light PA, SB and 
Echocardiographic Measures in Healthy-Subgroup 
Outcome MVPA Light PA  SB 
LVMI, g/m2 -0.053 0.053 -0.037*
LVMI2.7/ EDV -0.0015 0.0008 -0.0005
LAVI, mlm2 
0.0371^ 0.0065  ^ -0.0079^
EF % 
0.0001 -0.0004 0.0003
E/e’ ratio 0.0184^ 0.0008* -0.0022^
GLS, % 
-0.0079^ -0.0023^ 0.0024^
SV, ml 0.1743^ 0.0038 -0.0188^
RV peak S, cm/sec 0.0056^ -0.0026 0.0015
RV FAC,% 0.0000 0.0000 0.0000
TRV Max, cm/sec 0.1234 0.0165 -0.0248*
TAPSE, cm 0.0018^ 0.0006^ -0.0006^
Regression model adjusted for demographics (age and sex), systolic blood pressure, antihypertensive med use, other cardiovascular 
disease modifiable factors (diabetes mellitus, glycosylated hemoglobin, current smoking, and high-density lipoprotein.  
*p-value < 0.01
^p value < 0.001
Values are per 10 min/day light MVPA/light PA/SB
MVPA = moderate to vigorous physical activity (PA); SB =sedentary behavior; LVMI =left ventricular mass index, EDV=end diastolic
volume, LAVI=left atrial volume index, EF=ejection fraction, E =peak early diastolic transmitral inflow velocities, e’ =average of mitral
early diastolic septal and lateral annular velocities, GLS =global longitudinal strain, SV =stroke volume, RV=right ventricular,
RVFAC= RV fractional area change, TRV= tricuspid regurgitation velocity, TAPSE = tricuspid annular plane systolic excursion
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